Group One Trading
LYEL icon

Group One Trading’s Lyell Immunopharma LYEL Stock Holding History

Group One Trading’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.1K Sell
1,000
-100
-9% -$2.34K ﹤0.01% 5963
2025
Q4 		$33.9K Sell
1,100
-1,600
-59% -$35.8K ﹤0.01% 5918
2025
Q3 		$43.8K Buy
+2,700
New +$30.8K ﹤0.01% 6073
2025
Q1 		– Sell
-150
Closed -$1.92K – 8044
2024
Q4 		$1.92K Hold
150
– – ﹤0.01% 6752
2024
Q3 		$4.14K Sell
150
-295
-66% -$8.67K ﹤0.01% 5948
2024
Q2 		$12.9K Buy
445
+435
+4,350% +$20.7K ﹤0.01% 5503
2024
Q1 		$446 Buy
+10
New +$428 ﹤0.01% 6754
2022
Q4 		– Sell
-10
Closed -$15K – 7736
2022
Q3 		$15K Buy
10
+5
+100% +$677 ﹤0.01% 6258
2022
Q2 		$1K Buy
+5
New +$511 ﹤0.01% 7574

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
GP
GSK plc London $599M AUM
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return